Tekle A, al-Khamis K I
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Kingdom of Saudi Arabia.
J Pharm Pharmacol. 1990 Nov;42(11):799-801. doi: 10.1111/j.2042-7158.1990.tb07025.x.
The effect of coadministration of bupropion (50 mg kg-1, p.o.) on the disposition profile of phenytoin has been studied in the rat. Plasma phenytoin concentration was measured serially for 10 h by HPLC. Bupropion had little or no effect on the pharmacokinetic parameters of an acutely administered dose of phenytoin. Following multiple doses of phenytoin however (i.e. steady state) the coadministration of bupropion resulted in significant increases in the elimination half-life (t 1/2), the area under the plasma concentration-time curve (AUC) and the time to maximum plasma concentration (tmax). Allowing for the limitations of single dose studies, these results point to a possible pharmacokinetic interaction between bupropion and phenytoin--the clinical significance of which needs to be assessed.
在大鼠中研究了安非他酮(50毫克/千克,口服)与苯妥英钠联合给药对苯妥英钠处置曲线的影响。通过高效液相色谱法连续10小时测定血浆苯妥英钠浓度。安非他酮对急性给予的苯妥英钠剂量的药代动力学参数几乎没有影响或没有影响。然而,在多次给予苯妥英钠后(即稳态),安非他酮的联合给药导致消除半衰期(t1/2)、血浆浓度-时间曲线下面积(AUC)和血浆浓度达峰时间(tmax)显著增加。考虑到单剂量研究的局限性,这些结果表明安非他酮与苯妥英钠之间可能存在药代动力学相互作用——其临床意义需要评估。